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Summary 
Transgenic mice expressing a major histocompatibility complex class II-restricted T cell receptor 
with specificity for a natural self-antigen, the fifth component of complement, were generated 
to analyze the mechanism of tolerance induction to a blood-borne self-protein.  In the absence 
of C5 protein thymocytes from T cell receptor transgenic mice develop into mature CD4 single 
positive cells which emigrate into the periphery and mount  C5-specific T  cell responses upon 
immunization with C5. In the presence of circulating C5 protein, CD4 single positive thymocytes 
do not develop. Negative selection occurs late in thymic ontogeny leaving the bulk of CD4 +  8 + 
thymocytes unaffected.  This  phenotype  may be due  to  a  delay in  contact  with  self-antigen 
presentation  which,  under physiological conditions,  is inefficient in  the cortex of C5 + mice, 
and therefore does not affect most immature double positive thymocytes. In contrast,  in vitro 
exposure to C5 --presenting dendritic cells or in vivo injection of C5 peptide results in deletion 
of double positive thymocytes.  C5 + transgenic  mice are tolerant  in vivo, but contain  T  cells 
in spleen and lymph nodes that secrete interleukin 2 and interferon 3, in response to C5 activation 
in  vitro.  When  crossed  onto  a  Rag1-/-  background  to  prevent  endogenous  T  cell receptor 
rearrangements,  these peripheral potentially autoreactive cells do not appear.  This indicates that 
endogenous T  cell receptor rearrangements  possibly leading to the expression of two receptors 
might  be a prerequisite  for their  survival and export into  the periphery. 
N 
'egative  selection of potentially  self-reactive T  cells is 
important  for  induction  and  maintenance  of  self- 
tolerance. A wide range of examples shows that tolerance in- 
duction in MHC class I-restricted T cells is to a large degree 
effected by physical deletion of immature CD8 +4 + thymo- 
cytes (1-3). In addition, nondeletional mechanisms like down- 
regulation of coreceptors (4), or TCR (5), and induction of 
anergy (6) prevent activation of potentially self-reactive cells. 
Tolerance in MHC class II-restricted T cells has likewise been 
attributed to the deletion of CD4 § 8 § thymocytes based on 
studies in which the cognate peptide was injected into trans- 
genic mice with an ovalbumin-specific,  class II-restricted TCR 
(7). It was unclear how self-tolerance is achieved in the pres- 
ence of a self-protein that requires internalization,  processing, 
and presentation by MHC class II molecules. To address this 
question we have generated transgenic  mice with  a MHC 
class II-restricted TCR specific for a natural circulating self- 
protein, the fifth component of complement (C5), and ana- 
lyzed development of transgenic  T  cells in the presence or 
absence of self-antigen. Furthermore,  the functional behavior 
of mature  T  cells  in  the periphery  of C5-  or C5 + TCR 
transgenic  mice was analyzed.  The  findings  are  that  C5- 
TCR  transgenic  mice  (CS-Tg +)  develop  single  CD4 + T 
cells with high levels of TCR. Mature cells in the periphery 
of these mice are activated by C5 protein to secrete IL-2 and 
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IFN-3'. C5 + transgenic mice (C5 §  +) do not develop ma- 
ture  CD4 +  single  positive  cells,  but  show  only  a  slight 
reduction in  the number  of CD4 §  + cells in the thymus. 
Thymic tolerance induction to this blood-borne self-antigen 
occurs late in development, probably at the transition to single 
positive cells, which may be due to delayed exposure to self- 
antigen presentation. Although C5 + transgenic mice appear 
fully tolerant  in vivo, their splenic T  cells can be activated 
to secrete IL-2 and IFN-y in response to C5 in vitro.  The 
presence of anergic,  but reactivatable C5-specific T  cells is 
confined to mice that  can undergo  endogenous  rearrange- 
ments of alternative TCR genes. C5 + transgenic mice bred 
onto a Rag1-/-  background do not have any T  cells in the 
periphery.  These data indicate that, similar to class I-restricted 
T  cells,  thymic deletion is the major mechanism  for toler- 
ance induction in class II-restricted T cells even if the onset 
of deletion may be delayed due to limitations in self-antigen 
presentation. The escape from this mechanism appears to be 
correlated to the capacity to undergo endogenous TCR rear- 
rangements. 
Materials and Methods 
Animals.  CBA/Ca (C5 +) and A/J (C5-) mice are maintained 
under  specific pathogen  free conditions at the National  Institute 
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kindly provided by Dr. F. Gervais at the Montr&l General Hospital 
Research Institute (Montr6al,  Canada) (8) and is now bred in Mill 
Hill. Rag1-/- mice were obtained from Dr. E. Spanopoulou (The 
Rockefeller University, New York)  (9). 
Generation of Transgenic Mice.  To generate transgenic mice we 
used the TCR from clone A18 isolated  from an A/J mouse im- 
munized with C5 protein (10). Its variable region is encoded by 
Vcd1.1(a)-JctTA37  and V/~8.3-DJf12.6. The c~ chain of the TCR 
was identified by reverse transcription of total RNA from A18 hy- 
bridoma cells and PCR with a panel of primers specific for respec- 
tive families of Vct chains and a Ccta primer from the constant 
region (11). The ~ chain variable region was identified by FACS  | 
(Becton Dickinson & Co., Mountain View, CA) staining with an- 
tibodies F23.1 (V/~8.1, 2, 3) (12) which stained positive, and anti- 
bodies KJ16 (V/38.1, 2) (13) and F23.2 (V/38.2) (14) which both 
did not stain hybrid A18. 
An NcoI-NcoI fragment containing the variable region of the 
ct chain was generated from total RNA by PCR with Pfu poly- 
merase and  enzyme  digestion. Oligonucleotides used for amplification 
were the Cc~a primer and the Vot11.1-specific mutational oligonu- 
cleotide: 5'-TTG CAG GAC CCA TGG GGA TCA GGT GGA 
GCA GAGT-Y. Full-length cDNA was reconstituted by ligation 
with a partial NcoI-NcoI fragment containing leader and constant 
c~ chain sequences ofF5 TCR in pATX (15, from D. Kioussis, Na- 
tional Institute for Medical  Research,  London, UK). Similarily, 
a PCR fragment encoding leader and variable region of the A18 
/3 chain was  trimmed with NcoI and Celll and inserted into a 
CellI-NcoI fragment of the F5/3 TCR chain cDNA in pATX. 
The cDNA constructs were sequenced and BamHI-XbaI (c~) and 
BamHI-EcoRI (/~) fragments were inserted into a blunt-ended 
EcoRI  site  of the  SalI-BamHI  fragment  of the  human  CD2 
minigene in pBluescript (16). After a BamHI-XbaI segment with 
the CD2 LCR was added, both t~ and B constructs were isolated 
as SalI-NotI  and SalI-XbaI fragments,  respectively,  purified by 
anion-exchange HPLC on a GenFax column (Waters-Millipore, Mil- 
ford, MA) and mixed together in equimolar quantities. The mix- 
ture was used for microinjections into CBA x  CBA oocytes. Tram- 
genic  founders  were  either  maintained  on  the  CBA  (C5 +) 
background  or backcrossed  to  A/J  (C5-)  or congenic A.C5 § 
mice. 
Cell Cultures.  For functional tests of C5 reactivity spleens from 
transgenic mice or nontransgenic controls were subjected  to en- 
zyme digestion with a cocktail of collagenase (1.6 mg/ml CLS4; 
Worthington Biochemical Corp., Freehold, NJ) and DNase (0.1% 
Fraction IX; Sigma Chemical Co., Poole, UK) for 60 min at 37~ 
Cell  suspensions  were  washed  twice  and  plated  into  96-well 
U-shaped microtiter plates  (Costar Corp., High Wycomb, UK) 
at a density of 2  x  105 cells/well in the presence  or absence of 
C5 or C5 peptide. The culture medium was Iscove's modified Dul- 
becco medium supplemented with 5% heat inactivated FCS, 2  x 
10 -3 M t-glutamine, 100 U/ml penicillin,  100/zg/ml streptomy- 
cin, and 5  x  10 -s M mercapoethanol. Supematant from cultures 
incubated for 48 h was tested for the presence of I1,2 by its ability 
to support the growth of the Ib2-dependent cell line, CTLL. Su- 
pernatant from cultures incubated for 72 h was tested for IFN-'y 
activity by a sandwich ELISA as previously described (17). Briefly, 
antibodies to mouse IFN-'y were used for coating ELISA plates, 
followed by the addition of supernatants to be tested for the pres- 
ence of IFN-3,, capture by a second biotinylated IFN-3'-specific an- 
tibody, and detection with Streptavidin conjugated with horseradish 
peroxidase. 
Bone Marrow Dendritic Cells as APC.  Bone marrow-derived 
dendritic ceils, generated as described previously (18) were used as 
APC  for the results  described in Figs.  2 and 6.  The source of 
GM-CSF was  supernatant from hypoxanthine-aminopterin-thy- 
midine-sensitive  Ag8653 myeloma cells transfected  with murine 
GM-CSF cDNA which was isolated from a T cell clone by PCR 
and inserted into the vector BCMGSNeo kindly provided by Dr. 
H. Karasuyama (Basel Institute for Immunology, Basel, Switzer- 
land) (19). Thymic dendritic cells and macrophages were isolated 
from C5 + mice as previously described  (18). 
C5 Antigen Preparation and C5 Peptide.  C5 was purified from 
ascites fluid by affinity chromatography as described (20). The C5 
epitope recognized by hybrid A18, which donated the transgenic 
TCR, was identified  after digestion of C5 by V8 endoproteinase 
(Boehringer Mannheim,  Mannheim,  Germany) and  subsequent 
separation ofpeptides on a reversed phase HPLC column. A func- 
tionally active fraction was sequenced and peptide 107-121 was syn- 
thesized by the National Institute of Medical Research  (NIMR) 
peptide synthesis  facility. 
In Vitro Apoptosis Set Up (22).  2  x  10  s thymocytes per well 
of a 96-well U-bottomed plate were cultured for 10-12 h with 2  x 
104/well dendritic cells in the presence or absence of C5 protein 
or peptide. Cells were then harvested and analyzed in FACS  | 
In Vivo Depletion of Double Positive Tkymocytes.  C5-Tg + mice 
received daily intraperitoneal injections for 6 d with 250 gl of 100 
/zM C5 peptide or with PBS. At various time points after peptide 
injection mice were killed and the thymus was analyzed by FACS  | 
FACS |  Analysis, Antibodies, and Magnetic Cell Sorting.  Analysis 
was performed on a FACSCAN (Becton Dickinson & Co.) using 
three-color staining with antibodies conjugated with FITC, PE, 
or biotin followed by streptavidin-Tricolor (Caltag Laboratories, San 
Francisco, CA). The transgenic B chain was detected with anti- 
body F23.1 which reacts with VB8.1,2,3  (12). CD4-PE was ob- 
tained from Becton Dickinson & Co., and CDS-FITC was pre- 
pared by FITC conjugation of antibody YTS169.4  (21).  DNA 
staining was done with 7-aminoactinomycin D  (7-AAD1; Sigma 
Chemical Co.) as follows: 5  x  10  s cells in V-bottomed plates were 
first stained for CD8-FITC and CD4-PE, washed once in PBS con- 
taining 0.01% sodium azide, 2% FCS and once again in PBS with 
0.3% saponin.  7-AAD (4/zg/ml in PBS-saponine) was then added 
and the plates were incubated at room temperature shielded from 
light for 30 min. Without a further washing step, the samples were 
then analzyed using linear scale for F1`3 acquisition to assess 7-AAD 
staining. 
Positive selection of T cells expressing Vc~2 TCR determinants 
was done by magnetic cell sorting with the Vario-MACS (Mfltenyi 
Biotech, Bergisch Gladbach, Germany) using biotinylated anti-Vtx2 
(22) antibody and following the procedure recommended in the 
manual.  Positively  selected  cells were passed  over the  selection 
column twice and the purity of the selected population was be- 
tween 80 and 90%. 
Results 
Generation of Transgenic Mice with a Class II-restricted TCR 
Specific for the Serum Protein  C5.  The A18 T  cell clone that 
donated the receptor used to generate transgenic mice is a 
high affinity clone that recognizes very small amounts of C5 
protein presented in the context of I-E  k MHC (10, 18).  The 
C5 epitope recognized is peptide 107-121 close to the NH2 
1 Abbreviation used in this paper: 7-AAD, 7-aminoactinomycin  D. 
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cloned and cDNAs for the cz and/3 chains were placed under 
the control of the human CD2 promoter and LCR region. 
The human CD2 cassette was previously shown to drive T 
lymphocyte-specific, copy number-dependent, and integra- 
tion site-independent expression of the class I-restricted TCR 
F5 (15). Five founders were identified upon injection of A18 
o~ and/3 constructs into CBA oocytes, varying in the copy 
numbers of transgene from 1 to 100.  One transgenic line, 
A18.2, with about 40 copies of the ot transgene and 30 copies 
of the/3 transgene, was selected for the following experiments. 
Thymic Development in C5- and C5 + Transgenic Mic~  The 
transgenic line A18.A was selected for further analysis be- 
cause its  TCR expression in the thymus closely followed 
normal T  cell development in nontransgenic mice as illus- 
trated in Fig. 1. In the absence of C5 (CS-Tg +) expression 
of this  class  II-restricted  receptor results  in  pronounced 
skewing of thymocyte development to CD4 + cells and vir- 
tually no generation of CD8 + cells. The TCR, analyzed by 
staining with the VB8-specific  antibody F23.1  is expressed 
very low on double negative CD4-8-  cells, is upregulated 
to intermediate levels in the double positive CD4 +  8 + popu- 
lation, and reaches maximum levels upon maturation to single 
positive CD4 + cells. This receptor development, particularly 
the  fact  that  double  negative  thymocytes  are  TCR -/]~ 
closely resembles the development in normal mice. 
In the presence of C5  (CS+Tg +) there is no generation 
of CD4 single positive cells. In contrast to most class I TCR 
transgenic mice on  a  deleting background,  however,  the 
number of CD4+8 + thymocytes is only marginally reduced, 
which is also reflected in similar total cellularity of the thymus 
from C5 + transgenic mice compared with C5- littermates. 
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Figure  1.  Thymocytes  from  a 
nontransgenic mouse, a C5- TCR 
transgenic mouse, and a C5 + TCR 
transgenic mouse were analyzed for 
the expression of CD4 and CD8 as 
well as TCR on gated populations. 
Staining for TCR was performed 
with antibody F23.1.  (.4) Thymic 
phenotype of transgenic mice in the 
absence of (C5-) or presence  (C5 +) 
of self-antigen. (B) TCRq3 chain ex- 
pression on gated population. 
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8 expression appears in the thymus of C5 + transgenic mice. 
The apparent TCK expression in the double negative popu- 
lation is probably due to cells that have downregulated TCRs 
and are in the process  of undergoing apoptosis.  It appears 
that tolerance induction to C5 under physiological conditions 
does not affect the majority of double positive cells, but only 
those at the transition to  single positive cells. 
Induction of Apoptosis in Double Positive Cells In Vitro.  C5 
is a circulating serum protein that has to be internalized and 
processed by MHC class II expressing APC in the thymus 
for tolerance induction. Previous studies of the C5 presenting 
capacity of APC populations in the thymus have indicated 
that the most ef~cient APC are thymic dendritic cells (18). 
This APC population resides in the medulla and the cortico- 
medullary border which means that the bulk of CD4 +  8 + 
cortical thymocytes may not have access to ef~cient C5 pre- 
sentation; this might explain the failure to delete double posi- 
tive cells. To address this possibility we set up in vitro sus- 
pension  cultures in  which we exposed  all  thymocytes to 
dendritic cells as APC in the presence or absence of C5. As 
previously reported, the contact of thymocytes in vitro with 
cognate antigen results in apoptosis,  which is first visualized 
by downregulation of CD4 and CD8 on double positive cells 
(23). As shown in Fig. 2 it was obvious that thymocytes from 
C5-  and C5 + transgenic mice initiated apoptosis upon con- 
tact with dendritic cells and C5 or C5 peptide whereas non- 
transgenic control thymocytes remained unaffected. The de- 
gree of apoptosis  was identical in C5 -  and C5 § thymocytes 
indicating that both contain the same number of potentially 
deletable CD4+8 +  thymocytes. When  ef~cient APC  can 
gain access to double positive cells in vitro these cells can 
be deleted; in vivo we believe this access is restricted. Down- 
regulation of CD4 and 8 correlated with a decrease in DNA 
staining as measured by triple staining for CD4, CD8, and 
DNA content (data not shown, but see Fig.  3) indicating 
that the cells had indeed initiated apoptosis. When transgenic 
thymocytes from C5 + or C5-  mice were exposed to mac- 
rophages or dendritic cells isolated from thymus of normal 
C5 §  animals without  any further addition  of antigen in 
vitro it was clear that only dendritic cells could induce apop- 
tosis in agreement with previous findings that indicated that 
only dendritic cells in the thymus were able to present C5. 
Apoptosis of  Double Positive  Cells In Viw  The in vitro apop- 
tosis results indicate that double positive cells can be deleted 
under conditions of optimal antigen presentation. To check 
whether this is true for double positive cells in vivo, we per- 
formed the following experiments. Previous studies with trans- 
genic mice bearing a MHC class II-restricted TCR specific 
for ovalbumin (7) had shown that peptide injection in vivo 
resulted in deletion of double positive thymocytes. We per- 
formed analogous experiments with the C5 peptide 107-121 
recognized by the A18 TCR.  Fig.  3 top shows the pattern 
of CD4 and CD8 expression at different times after daily in- 
traperitoneal injection of C5 peptide (or PBS in the control 
group).  In addition triple staining with the DNA marker 
7-AAD, CD4,  and CD8 was performed to visualize apop- 
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Figure  2.  Thymocytes  from a C5- (O), a C5 + (I) TCR transgenic 
mouse, and a nontransgenic  control (I) were cultured for 12 h with den- 
dritic cells in the absence of C5 or with different doses of C5 protein  or 
C5 peptide.  The results shown in the third panel were obtained  by cul- 
turing thymocytes in the presence of different cell numbers of thymic mac- 
rophages  or dendritic  cells isolated from thymus of normal C5 + mice. 
CD4 and CD8 expression was analyzed by FACS  |  The results are ex- 
pressed as the percentage of bright double positive cells in relation to thymo- 
cytes cultured with dendritic  cells in the absence of antigen.  In the third 
panel the negative  control population  consisted  of thymocytes  without 
any added cells. 
tosis and cell division. Since there are practically no CD8 single 
positive cells in these mice, all cells that stained positive for 
CD8  are CD4+8 +  and  those that  do not  stain  are CD4 
single  positive  and  double  negative  thymocytes.  7-AAD 
staining is shown on a linear scale and as indicated in Fig. 
3, bottom the top fraction labeled I represents dividing cells 
in S and M phase with the double content of DNA, fraction 
II represents cells in G1 phase,  and fraction III contains cells 
with reduced amounts of DNA due to apoptosis.  As early 
as 10 h after peptide injection a significant downregulation 
of CD4 and 8 molecules can be observed which is paralleled 
by the appearance of an apoptotic cell population within the 
double positive cells (characterized by their reduced 7-AAD 
staining). After 2 d, double positive cells have virtually dis- 
appeared and the size of the thymus is reduced from 160  x 
106 to 6  x  106 cells. No apoptotic cell population is visible 
by DNA staining anymore, indicating that deletion and apop- 
tosis have been completed by this time. A  seemingly CD8 
single positive cell population becomes visible on day 2 and 
more pronounced on day 6, presumably because of its propor- 
tional representation within a thymus devoid of double posi- 
tive cells. We conclude that in a situation where the require- 
ment for antigen internalization and processing is removed, 
double positive cells are deleted, indicating that MHC class 
II positive cells in the cortex are able to present C5 for toler- 
ance induction under these conditions. It should be noted, 
however, that in the late phase after peptide injection, acti- 
vated mature CD4 + might exacerbate deletion via secretion 
of mediators such as TNF. 
Functional Activity of Mature Peripheral T  Cells from C5- 
and C5 + Transgenic  Mice.  Spleen cells from C5-  transgenic 
mice when cultured with C5 in vitro secrete IL-2 and IFN-y 
in response to as little as 10 ng/ml antigen (Fig. 4). We have 
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Figure  3.  C5- TCK transgenic mice were injected  daily  with 250 pl of 100 #M C5 peptide intraperitoneally  for 6 d. At 10 h, 2 d, or 6 d a mouse 
was killed for analysis  of CD4, CDS, and DNA content in thymocytes.  The total thymus cell number recovered from each mouse is given. DNA 
staining by 7-AAD on a linear scale  vs. CD8 on a log scale is shown  on the bottom. Regions  I, II and III refer to cells with double, single, or reduced 
content of DNA as outlined in Results. 
not observed any IL-4 production by these cells. Upon C5 
injection, lymph node cells from C5-  transgenic mice up- 
regulate CD69 and CD25  (data not shown). Peripheral  T 
cells from C5 § transgenic mice on the other hand do not 
show signs of activation in vivo. However, they contain cells 
that can be induced to secrete IL-2 and IFN-'y upon culture 
with C5 in vitro, indicating that some cells escape tolerance 
induction in the thymus and are maintained in an anergic 
state in vivo (Fig.  5). In the absence of a donotype-specific 
antibody, we have not been able to identify these cells since 
endogenous TCR rearrangements  that take place in these mice 
allow accumulation in the periphery of CD4 and CD8 single 
positive cells that bear nontransgene-derived receptors. 
Is C5 Tolerance  Induction Incomplete  Due to Limited Amounts 
of  Circulating C5 Early in Ontogeny?  The question arises how 
C5-specific  T  cells escape into the periphery of C5 + trans- 
genic mice. An earlier study investigated the postnatal ontogeny 
of potentially autoreactive cells specific for an Mlsa-encoded 
determinant. Thymocytes bearing VB6  were detectable in 
Mls  a mice neonatally and up to 4 d, but rapidly decreased 
thereafter (24). We considered the possibility that a delay in 
optimal C5 expression early in ontogeny might likewise allow 
some C5-specific CD4 cells to escape from thymic tolerance 
induction. 
C5 synthesis is demonstrable as early as day 10 of gesta- 
tion (25).  However, adult levels of C5 in the circulation are 
not reached until several weeks after birth.  C5 is a serum 
protein of medium abundance with average levels of 10-7 M 
(about 50/~g/ml) in adult male mice, and approximately half 
those levels in female mice (26).  Its expression  is governed 
by a single gene and F1 progeny between a C5 + and a C5- 
strain harbor half the concentration of C5 (27). It is also im- 
portant to note that C5 does not cross the placenta. Given 
the constraints of age, sex, and haplotype for concentration 
of the antigen, it is unclear what levels of circulating C5 are 
found at the time of early T cell differentiation and whether 
they are sufficient to fully prevent the emergence of mature 
single CD4 + cells. We reasoned that there might be a win- 
dow in the ontogeny of C5 + mice, especially C5 +/-  mice, 
in which CD4 single positive cells might be allowed to de- 
velop due to limited amounts of self-antigen present for toler- 
ance induction. If that were the case one could assume that 
the peripheral cells from C5 + transgenic mice which were 
found to be C5 reactive in vitro might have arisen from such 
an early wave of CD4 cells that had escaped tolerance induc- 
tion in the thymus. 
To test this hypothesis we isolated thymi from mice at day 
19 of gestation and tested them for the presence of C5 reac- 
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Figure 4.  Cells  from enzyme digested spleen of a C5- TCK transgenic 
mouse and a nontransgenic C5- control mouse were cultured in 96-well 
plates with different doses of C5 protein. For analysis of I1:2 production, 
75 #1 of culture supematant were removed  after 48 h of culture and tested 
on the Ib2-dependent CTLL line. R~ults are expressed as mean cpm (tripli- 
cate cultures) of incorporated [3H]thymidine. For assessment of IFN-3, 
release 75 #1 supernatant were removed after 72 h of culture and tested 
in ELISA. The results are expressed as arbitrary units of OD at 414 nm. 
tive cells as well as for C5 presentation capacity which was 
read out as activation of a C5-specific T  cell hybrid. Fig. 6 
A  shows the IL-2 response of thymocytes from individual 
day 19 fetuses from C5-/-,  C5 +/-,  and C5 + / + transgenic 
mice after in vitro culture with dendritic cells  and C5. The 
result unambiguously demonstrates that tolerance induction 
is complete at day 19 as there is no reactivity in C5 +  / + or 
C5 +/-  mice,  while  C5-specific  responses  in  thymocytes 
from C5-/-  mice are readily detectable  at  that  time.  The 
reciprocal test  for the presence of in vivo processed C5 on 
day 19 (Fig. 6 B) shows that thymus APC from all C5 + fe- 
tuses could be recognized by the C5-specific T  cell hybrid 
A18. There are considerable differences in the levels of stim- 
ulation and it is obvious that adult C5 ÷ thymi show higher 
C5 presentation than day 19 thymi; nevertheless the amounts 
of C5 present at that time are sufficient to prevent matura- 
tion of CD4 single positive cells.  This result rules out the 
possibility that CS-specific T  cells  in the periphery of C5 + 
transgenic mice have arisen from an early escape of CD4 single 
positive cells. 
Phenotype of Thymus and Spleen T Cells in C5- and C5 + 
Transgenic Mice Crossed onto the Ragl-/-  Background.  As 
mentioned previously, endogenous TCR rearrangements that 
are detectable in C5 + transgenic mice (and to a much lower 
degree in C5- littermates) make the identifcation of poten- 
tially  autoreactive  cells  difficult  since  we  do  not  have  a 
clonotype-spedfic antibody.  In addition we wanted to find 
out whether suppressor cells are involved in maintenance of 
C5 tolerance as has been suggested by Cairns et al.  (28). We 
therefore crossed our transgenic  mice with  mice homozy- 
gous for the Rag1 gene deletion to prevent rearrangements 
of endogenous TCR genes so that the only lymphoid cells 
in this system would be C5-specific T  cells.  A shown in Fig. 
7, C5- Rag-  transgenic mice show CD4 single positive cells 
with mature levels of T cell receptor in thymus and the only 
lymphoid cells found in lymphnodes (and spleen) are CD4 ÷ 
T  cells  with transgenic TCRs.  These cells can be activated 
in vivo and in vitro and behave identically to their CD4 court- 
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Figure  5.  Cells  from enzyme digested spleens of a C5  l  ~R  trans- 
genic mouse, five individual C5 + TCR transgenic mice and a nontrans- 
genic control were cultured in 96-well plates in the presence or absence 
of different amounts of  C5 as indicated. After 48 h of  culture, 75/xl super- 
natant were removed for analysis of I1:2 activity on the I1-2-dependent 
CTLL line. Results are expressed as mean cpm (triplicate cultures) of in- 
corporated [3H]thymidine. For assessment of IFN-? release 75/zl super- 
natant were removed  after 72 h of  culture and tested in ELISA.  The results 
are expressed as arbitrary units of OD at 414 rim. 
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Figure  6.  Thymus suspensions from day 19 embryos ofC5-Tg + (five 
embryos), C5+Tg + (four embryos) or F1 between these two strains (four 
embryos) and an adult C5 +Tg  + control were prepared by enzyme diges- 
tion. In A, 2 x  10  s thymocytes/well  of a 96-weU plate were cultured with 
2 x  104 dendritic cells in the presence of I/xM C5 peptide for 48 h. 75 #1 
of supernatant were then removed and tested for II:2 activity on CTLL 
cells. In B, the same thymus cell suspensions were irradiated with 200 Gy 
and cultured at 2  x  104 cells/well with 5  x  104 cells/well of the A18 
T cell hybrid. 24 h later supernatants were transferred to CTLL cells for 
assessment of II-2 activity. The results are expressed as mean cpm (tripli- 
cate cultures) of incorporated [3H]thymidine. 
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lymphoid cells has not prevented the functional development 
of transgenic T cells. In the thymus of C5 +  Rag- transgenic 
mice, mature single positive CD4 ceils are absent. The number 
of double positive cells  in C5 +Rag-  is slightly decreased 
compared with C5- littermates, but the thymic phenotype 
is very similar to  that  in young Rag+C5 + mice.  Spleens 
(and lymph nodes) of C5 +Rag-  mice do not contain any 
CD4 + cells (and in fact no lymphoid cells with expression 
of Thyl either) and no functional activity in vitro.  These 
results document that tolerance induction by deletion of MHC 
class l-restricted T  cells specific for circulating C5 is very 
stringent and that there seems to be no escape of calls through 
downregulation of TCR or coreceptor. 
CS +  Kag + Transgenic Mice Contain T  Cells with Endogenous 
TCR o~ Chains and the Transgenic C5 Reactivity.  The demon- 
stration of CS-specific  T  cells that appear in the periphery 
of C5 +  Rag + transgenic mice, but not C5 +  Rag-  transgenic 
mice implies endogenous TCK rearrangements rescue C5- 
specific T  eels during selection in the thymus. In this con- 
text a crucial question is whether the C5-specific cells in 
C5 +  Rag + transgenic mice carry a single CS-specific endog- 
enous TCK unrelated to the transgenic receptor or have two 
receptors, the transgenic one and an additional endogenous 
receptor that mediated thymic selection. The first possibility 
is unlikely since a single endogenous receptor conferring C5 
specificity would have been subject to tolerization as it is in 
nontransgenic C5 + mice. Spleen cells from C5 + transgenic 
mice mount a rapid primary C5-specific response in vitro in 
contrast to normal C5 + or C5- mice. It therefore seems rea- 
sonable to assume that the transgenic receptor is involved in 
the response of C5+Rag + transgenic mice. The most ob- 
vious test for this hypothesis would be double staining for 
the transgenic TCR Vot chain and any given endogenously 
derived Vo~ chain (allelic exclusion for the transgenic TCR 
chain is t>90%).  Unfortunately, the available antibodies 
against Vot11.1 do not react with the Vc~ haplotype of the 
A/J strain (29) so that the transgenic TCK Vo~ cannot be 
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Figure  7.  Thymus (top) and lymph node cells (bottom) of a C5-  Rag -i-  Tg + mouse and a C5 + Rag-l-  Tg+  mouse were analyzed for CD4 and 
CD8  expression.  The level of TCR  expression in CD4 +  lymph node  cells is shown in an inset  as assessed by staining with antibody F23.1. 
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identified by its reactivity against the A18 peptide epitope 
of C5. We therefore ohose to positively select T cells expressing 
TCR Vot2 determinants which can be identified with an an- 
tibody (22) and test the reactivity of Vc~2 expressing T cells 
to C5 and the A18 peptide in comparison with nontrans- 
genic C5 + and nontransgenic C5-  mice. 
As shown in Fig. 8, Vot2-expressing T cells, purified from 
spleen cells of C5 + transgenic mice by magnetic cell sorting, 
react to C5 protein and the peptide epitope recognized by 
the transgenic TCR.  No response was detectable in Vc~2 T 
cells from C5 + nontransgenic mice or in cells from nonim- 
mune C5-  mice. C5-  nontransgenic mice immunized with 
whole C5 protein react to C5 in vitro, but only marginally 
to the transgenic TCR epitope which is not well represented 
in the random repertoire of C5 reactive T cells. We therefore 
conclude that a significant proportion of C5-specific T cells 
detected in  CS+Rag ÷ mice carry Vot2 together with  the 
transgenic receptor (and presumably the transgenic B chain). 
It is likely that other Vc~ determinants are similarly repre- 
sented on cells expressing transgenic TCR. 
Discussion 
This study analyzes the mechanism of tolerance in mice 
with a transgenic TCR specific for the serum protein C5. 
C5 is a natural self-protein that causes complete T cell toler- 
ance in mice that express it, whereas no tolerance is induced 
in CS-deficient strains of mice which lack C5 in their circu- 
lation. The basis of tolerance was unknown and suppressor 
cells were reported to be involved in its maintenance. C5 TCR 
transgenic mice allowed us to investigate the mechanisms un- 
derlying induction and maintenance of tolerance under phys- 
iological conditions of antigen expression in vivo by crossing 
Figure  8.  Spleens were taken from C5 + nontransgenic  (ntg) and C5 + 
transgenic (Tg +  ) mice and V~2-bearing  T cells were purified by magnetic 
cell sorting.  Spleens from nontransgenic  C5-  mice were taken from ei- 
ther untreated  animals (ntg) or mice primed with C5 in alum 14 d before 
(imm.).  Spleen cells were cultured in the presence of 5 #g/ml C5 or 1/~M 
A18 peptide  (107-121) for 48 h. Supernatants  were transferred  to CTLL 
cells for assessment of II.-2 activity. The results are expressed as mean cpm 
(triplicate  cultures)  of incorporated  [3H]thymidine. 
C5-  mice that express the transgenic receptor with normal 
C5 + mice. The results of these experiments show unequivo- 
cally that C5 + transgenic mice are tolerized by negative se- 
lection of CD4 single positive thymocytes. Deletion of self- 
reactive cells obviously occurs late in thymic ontogeny be- 
cause the CD4+8 + population is not depleted in our mice. 
In other class II TCR  transgenic mice, as far as thymic 
tolerance induction has been analyzed, deletion of CD4 +  8 + 
thymocytes was observed after injection of cognate peptide. 
Also transgenic mice bearing a dass II-restricted TCR specific 
for an epitope on the immunoglobulin ~ chain showed dele- 
tion of double positive cells when these mice were crossed 
to mice transgenic for the ~ chain (30).  Since the transgene 
in the latter mice was expressed under the control of the Ig 
heavy chain promoter, deletion was attributed to intrathymic 
synthesis of the ~, chain which presumably supplied high local 
concentrations of antigen rather than to an effect of blood- 
borne antigen. In fact serum levels ofS00/~g/ml after repeated 
injections of X immunoglobulin were required before dele- 
tion of double positive cells in the thymus was detectable. 
Several possibilities  could account for differences observed 
in intrathymic stages of deletion. First, the level of TCR ex- 
pression at different stages of T cell ontogeny in the thymus 
must play an important role in susceptibility to negative se- 
lection. The majority of TCR transgenic mice show high 
levels of  TCR expression already at the double negative stage 
which is not seen in normal mice. This will clearly enhance 
the chance of negative selection and certainly contributes to 
the findings that positive and negative selection can occur 
simultaneously. We chose a transgenic line for this study in 
which TCR  expression follows that  seen in normal mice. 
However, our data disputes the simple notion that insuffcient 
receptor expression caused the delay in negative selection. 
Clearly double positive cells could be deleted when cultured 
with dendritic APC in vitro and after injection of the cog- 
nate peptide in vivo. 
Another possibility is that exposure to negatively selecting 
antigen is delayed in our mice because it requires internaliza- 
tion and presentation by dendritic cells that are found in the 
thymic medulla, but not the cortex where the bulk of double 
positive thymocytes resides (31). Our data do not exclude 
a role for medullary epithelium (32) as APC for negative se- 
lection, but we know that thymic macrophages are incapable 
of presenting exogenous protein because their levels of class 
II are very low. Cortical epithelial cells, on the other hand, 
express high levels of class II molecules, yet seem unable to 
present C5 for negative selection as judged by the fact that 
double positive cells are present under physiological condi- 
tions in C5 + mice. This failure to present may be due to 
their relative inefficiency in internalization of exogenous pro- 
tein, the absence ofcostimulatory molecules (33, 34), and/or 
to the possibility that the cortex does not get access to the 
full amount of C5 present in the blood circulation. Although 
proteins have been shown to enter the cortex through the 
transcapsular  route  (35),  this  may  not  be  as  efficient  as 
the blood supply which carries circulating proteins into the 
medulla. Thymic nurse cells as representatives of cortical ep- 
ithelium have been shown to present intravenous injected pro- 
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detect its presentation  by nurse cells (36). It is quite likely, 
however, that self-proteins that are more abundant than C5 
can get presented by cortical epithelial cells, which might 
result in the deletion of double positive cells. This interpre- 
tation is in agreement with the results in X light chain-specific 
TCK transgenic mice. These mice show deletion of double 
positive thymocytes if the serum concentration of X chain 
reaches levels >500 #g/ml, which is about 10-fold more than 
the average C5 concentration. 
The conclusion we would like to draw is that the onset 
of negative selection in the thymus depends on the overall 
avidity of interactions  that are determined partly by TCR 
expression, and partly by the number of MHC/peptide com- 
plexes that are presented. The latter may rarely be limiting 
for class I-restricted TCKs because of the abundance of class 
I-expressing cells in the thymus. If the avidity of interac- 
tions is high at an early stage of thymocyte development, 
negative  selection will delete the CD4+8 § compartment. 
For class II-restricted receptors specific for extracellular an- 
tigens,  the need for antigen internalization  and processing 
by MHC class II-expressing  APC is an obvious limitation 
to receive high avididy signals for negative selection in the 
cortical stage of development. When the antigen supply be- 
comes limiting only dendritic cells might be able to provide 
sufficient MHC/peptide complexes, thus restricting presen- 
tation for negative  selection  to  the medulla and cortico- 
medullary  junction and hence a relatively late stage in thymo- 
cyte development. Likewise in MHC dass I TCK transgenic 
mice once the antigen density becomes limiting, the elimi- 
nation of double positive cells is less pronounced (37). Regard- 
less of the delayed onset of negative  selection  the results 
presented  show that  thymic deletion of T  cells with C5 
specificity is the major mechanism of tolerance induction. 
Considering the high incidence of autoimmune disorders 
with involvement of MHC class II-restricted cells, we had 
anticipated that negative selection by clonal deletion might 
be less stringent in this compartment compared with MHC 
class I-restricted T cells. The inherent limitations of presen- 
tation for exogenous antigens, such as threshold concentra- 
tions that have to be reached and the need for internalization 
and processing by MHC class II positive APC raised the pos- 
sibility that some T cells might escape thymic negative selec- 
tion. Despite the fact that C5 levels are low early in develop- 
ment and adult amounts of C5 in the circulation are not found 
until several  weeks after birth, there was sufficient self-antigen 
present to prevent maturation of CD4 single positive cells 
at day 19. Preliminary experiments using fetal thymic organ 
cultures  have indicated  that a day 14 fetal thymus from a 
C5 + transgenic  mouse can generate CD4 + single positive 
cells after 10 d of culture indicating that the C5 levels at that 
time are not high enough for sustained presentation in vitro 
in the absence of ongoing C5 supply. Thus, between days 
14 and 19 C5 synthesis increases sufficiently to supply the 
levels of C5 needed for tolerance induction. The demonstra- 
tion of C5-specific T cells in these mice which are nonrespon- 
sive in vivo, but are activatable in vitro at face value sug- 
gested leakiness of the thymic tolerance process. In view of 
the results with Rag- C5 + transgenic mice in which we do 
not find any evidence of T cells escaping into the periphery, 
however, this notion has to be modified. The findings rule 
out a number of possibilities which could have accounted 
for the presence of potentially self reactive cells in C5 + mice. 
First,  they show that clonal deletion is complete and that 
there is no significant leakage into the periphery of cells with 
downregulated receptors or coreceptors, at least up to the 
relatively young age of 8 wk. Second, the results rule out 
the contribution of suppressor T cells to the tolerant  state 
since their absence in Rag1-  mice should have resulted in 
accumulation of autoreactive  cells. Third, our findings strongly 
suggest that endogenous rearrangements might be involved 
in creating a potentially autoreactive repertoire of cells in the 
periphery. 
One possibility is that endogenous rearrangements  have 
created receptors composed of the transgenic ~ chain with 
an endogenous c~ chain that by chance convey C5 specificity. 
The reason why this possibility seems relatively unlikely is 
that C5-specific cells detected in C5 § transgenic mice have 
the same fine specificity as the correct transgenic  receptor 
recognizing peptide 107-121, whereas the random repertoire 
of C5-specific T cells is diverse and does not focus onto this 
particular epitope. An alternative possibility is that autoreac- 
rive cells might carry two receptors, the transgenic receptor 
and an additional receptor using a different o~ chain. Incom- 
plete allelic exclusion of the ot chain has been demonstrated 
to result in productive rearrangement of two different c~ chains 
in T cell clones, although technical difficulties prevented their 
detection on the cell surface (38). Recently, the expression 
of two different TCKs on cells from transgenic mice was de- 
scribed (39). This phenomenon is not restricted to transgenic 
mice or T cell dones, but appears to occur frequently in normal 
T cells as indicated by a study that detected two receptors 
on about 30% of normal human T cells (40). In our study 
T cells of C5 + transgenic mice carrying a TCR-o~ chain un- 
related to the transgenic TCK were shown to react with the 
fine specificity of the transgenic receptor. This supports the 
assumption  that they express a second receptor that allows 
their positive selection and exit into the periphery. The signals 
involved in this process and the mechanisms that (a) keep 
the transgenic receptor unreactive in vivo and (b) allow its 
activation in vitro are presently unknown, but their elucida- 
tion should give important insight into the generation of au- 
toimmunity. 
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